| Quarterly Financials | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
Revenue  | 54 | 116 | 103 | 116 | 126 | 116 | 114 | 119 | 107 | 124 | 117 | 126 | 127 | 146 | 138 | 159 | 160 | 188 | 174 | 179 | 195 |
| Expenses | 38 | 62 | 54 | 58 | 66 | 62 | 63 | 68 | 65 | 72 | 69 | 72 | 73 | 82 | 82 | 92 | 95 | 107 | 102 | 105 | 115 |
| EBITDA | 16 | 54 | 49 | 59 | 60 | 54 | 51 | 51 | 43 | 52 | 48 | 54 | 54 | 64 | 55 | 66 | 65 | 81 | 72 | 73 | 81 |
| Operating Profit % | 27 % | 45 % | 46 % | 49 % | 46 % | 45 % | 43 % | 41 % | 38 % | 40 % | 39 % | 41 % | 40 % | 41 % | 38 % | 41 % | 39 % | 42 % | 40 % | 39 % | 39 % |
| Depreciation | 12 | 14 | 13 | 13 | 12 | 13 | 13 | 15 | 14 | 16 | 20 | 11 | 13 | 14 | 15 | 16 | 17 | 17 | 18 | 19 | 21 |
| Interest | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 5 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 7 | 7 | 7 | 8 |
| Profit Before Tax | 1 | 36 | 33 | 43 | 44 | 38 | 34 | 31 | 24 | 31 | 22 | 37 | 36 | 45 | 35 | 44 | 42 | 57 | 47 | 47 | 52 |
| Tax | -1 | 9 | 8 | 11 | 11 | 10 | 8 | 8 | 6 | 8 | 6 | 9 | 9 | 11 | 9 | 10 | 10 | 15 | 11 | 13 | 14 |
| Net Profit | 2 | 27 | 25 | 32 | 33 | 28 | 26 | 24 | 18 | 24 | 17 | 28 | 26 | 34 | 26 | 34 | 32 | 42 | 35 | 35 | 39 |
| EPS in ₹ | 3.55 | 2.59 | 2.43 | 3.08 | 3.23 | 2.72 | 2.48 | 2.33 | 1.71 | 2.29 | 1.60 | 2.69 | 2.57 | 3.26 | 2.53 | 3.27 | 3.06 | 4.09 | 3.42 | 3.38 | 3.76 |
Vijaya Diagnostic Centre
Vijaya Diagnostic Centre
993.00
-7.35
(-0.73%)
Key Fundamentals
Market Cap
10,200.59 Cr
EPS
13.95
PE Ratio
68.03
Dividend Yield
0.20 %
Industry
Healthcare Services 52 Week High
1,275.00
52 Week Low
740.00
PB Ratio
12.89
Debt to Equity
0.40
Sector
Healthcare Service Provider Analyst Rating and Forecast
- By Refinitiv from7 analysts
Actual
Company News
View All News
V. Siva Rama Raju Vegesna, Operations Vice President at Vijaya Diagnostic Centre, has resigned for personal reasons with effect from November 8, 2025. The company acknowledged his six-year service period with the organization.
The National Company Law Tribunal (NCLT) in Hyderabad has delayed its decision regarding the proposed merger between Vijaya Diagnostic Centre and Medinova Diagnostic Services. The tribunal has not yet approved the merger plan between the two diagnostic companies.
Vijaya Diagnostic Centre Limited delivered consolidated revenue of Rs. 188 crores for the quarter ended June 30, 2025, representing a 20.4% year-on-year growth. The company achieved an EBITDA margin of 39.1% and PAT margin of 20.4%. Revenue growth was driven by 17% test volume growth and 14% patient footfall increase, along with changes in test mix. The Hyderabad market returned to double-digit growth this quarter. The company commissioned five new hubs and one spoke during the quarter across Pune, Bangalore, and West Bengal. Radiology contributed 39% of revenue mix while pathology accounted for 61%. The Nizamabad hub center achieved breakeven within two quarters of operations. One Bangalore hub center is on track to reach breakeven earlier than the estimated 12-month timeline. The company maintains its plan to open 10 hubs in the current financial year. Cash position stood at Rs. 270 crores as of June 30, 2025, with net cash of Rs. 220 crores after capital creditors. Wellness segment contributed 14.2% to revenue compared to 13.5% in the previous year. The company guided for CAPEX of Rs. 150-155 crores for new centers in FY26, with replacement CAPEX at 2-3% of topline.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
3,071.90 | #1 25,735.00 | 51.91 | #1 2,554.80 | 11.28 | #1 492 | 24.30 | 43.36 | |
2,020.50 | 10,467.70 | 70.50 | 1,346.30 | 10.64 | 146 | 18.90 | 53.99 | |
993.00 | #3 10,200.59 | #8 68.03 | #6 699.70 | #3 23.06 | #3 144 | #4 22.54 | 37.36 | |
1,231.50 | 6,526.27 | 60.19 | 702.20 | 20.80 | 91 | 60.25 | 50.10 | |
825.20 | 2,676.84 | 31.45 | 742.70 | 16.70 | 78 | 14.53 | 50.76 | |
293.95 | 1,530.91 | 47.12 | 255.90 | 15.11 | 31 | 19.48 | 38.62 | |
1,410.90 | 1,234.04 | 24.80 | 111.60 | 28.72 | 48 | 11.50 | 45.18 | |
315.00 | 1,002.03 | #1 10.73 | 1,170.80 | -18.47 | -134 | -35.12 | 55.80 | |
275.00 | 547.00 | 20.73 | 147.80 | #1 134.60 | 19 | #1 444.44 | 51.52 | |
187.00 | 124.97 | 82.50 | 41.80 | 13.28 | 2 | 0.00 | 41.36 |
Growth Rate
Revenue Growth
23.06 %
Net Income Growth
20.23 %
Cash Flow Change
22.46 %
ROE
-0.77 %
ROCE
-1.44 %
EBITDA Margin (Avg.)
-1.98 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 234 | 301 | 482 | 541 | 714 | 853 | 983 | 1,274 |
| Fixed Assets | 119 | 151 | 272 | 268 | 371 | 524 | 742 | 865 |
| Current Assets | 103 | 138 | 186 | 239 | 270 | 276 | 211 | 307 |
| Capital Work in Progress | 3 | 3 | 10 | 9 | 34 | 28 | 9 | 70 |
| Investments | 73 | 69 | 55 | 28 | 54 | 139 | 109 | 185 |
| Other Assets | 39 | 78 | 146 | 236 | 255 | 163 | 123 | 154 |
| Total Liabilities | 234 | 301 | 482 | 541 | 714 | 853 | 983 | 1,274 |
| Current Liabilities | 40 | 50 | 59 | 44 | 66 | 66 | 73 | 163 |
| Non Current Liabilities | 33 | 40 | 150 | 138 | 178 | 241 | 250 | 312 |
| Total Equity | 161 | 211 | 274 | 359 | 470 | 547 | 660 | 799 |
| Reserve & Surplus | 155 | 204 | 270 | 355 | 458 | 535 | 647 | 786 |
| Share Capital | 5 | 5 | 5 | 5 | 10 | 10 | 10 | 10 |
Cash Flow
| Cash Flow | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | -44 | -7 | 46 | -49 | 4 | 13 | -2 | -9 |
| Investing Activities | -98 | -90 | -31 | -130 | -123 | -110 | -141 | -182 |
| Operating Activities | 62 | 91 | 106 | 130 | 158 | 165 | 183 | 225 |
| Financing Activities | -8 | -7 | -30 | -49 | -31 | -42 | -45 | -52 |
Share Holding
| % Holding | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
| Promoter | 60.00 % | 54.78 % | 54.78 % | 54.78 % | 55.04 % | 55.01 % | 55.01 % | 55.01 % | 54.98 % | 54.90 % | 54.87 % | 54.06 % | 53.93 % | 53.91 % | 53.91 % | 53.05 % | 52.63 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 20.09 % | 20.08 % | 18.14 % | 17.54 % | 19.36 % | 19.56 % |
| DIIs | 0.00 % | 14.09 % | 13.30 % | 12.88 % | 12.76 % | 15.28 % | 14.23 % | 13.90 % | 19.03 % | 17.99 % | 19.55 % | 20.80 % | 21.49 % | 23.46 % | 24.63 % | 23.72 % | 24.07 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 0.00 % | 5.45 % | 3.71 % | 3.82 % | 4.00 % | 4.97 % | 5.18 % | 5.13 % | 5.03 % | 5.06 % | 4.63 % | 4.38 % | 3.98 % | 3.94 % | 3.43 % | 3.42 % | 3.24 % |
| Others | 40.00 % | 25.68 % | 28.21 % | 28.52 % | 28.20 % | 24.74 % | 25.58 % | 25.96 % | 20.96 % | 22.05 % | 20.95 % | 0.67 % | 0.52 % | 0.55 % | 0.49 % | 0.45 % | 0.50 % |
| No of Share Holders | 7 | 2,34,724 | 82,139 | 79,021 | 77,229 | 76,985 | 79,059 | 76,532 | 73,850 | 72,795 | 66,204 | 66,724 | 62,415 | 62,258 | 60,952 | 66,891 | 62,115 |
Dividend History
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1 | 1 | 1 | 2 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.25 | 0.16 | 0.1 | 0.2 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 21 Sept 2022 |  Dividend | ₹ 1.00 /share | 20 Sept 2022 | 389.20 | 402.80 |
| 13 Sept 2023 | Dividend | ₹ 1.00 /share | 13 Sept 2023 | 376.05 | 473.60 |
| 30 Aug 2024 | Dividend | ₹ 1.00 /share | 30 Aug 2024 | 666.50 | 892.05 |
| 06 Sept 2024 |  Annual General Meeting | NA | 06 Sept 2024 | 819.35 | 948.50 |
| 07 Nov 2024 |  Quarterly Result Announcement | NA | 07 Nov 2024 | 933.90 | 980.25 |
| 12 Feb 2025 | Quarterly Result Announcement | NA | 12 Feb 2025 | 1,159.65 | 1,076.90 |
| 25 Apr 2025 |  Extraordinary General Meeting | NA | 25 Apr 2025 | 1,050.75 | 1,061.30 |
| 12 May 2025 | Quarterly Result Announcement | NA | 12 May 2025 | 1,017.75 | 993.85 |
| 28 Jul 2025 | Quarterly Result Announcement | NA | 28 Jul 2025 | 1,045.40 | 1,070.30 |
| 29 Aug 2025 | Dividend | ₹ 2.00 /share | 29 Aug 2025 | 993.85 | 993.45 |
| 05 Sept 2025 | Annual General Meeting | NA | 05 Sept 2025 | 1,049.85 | 1,088.45 |
Announcements
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
5 days ago
5 days agoResignation Of Vice President - Operations (Mr. V. Siva Rama Raju Vegesna)7 days ago
7 days agoAnnouncement under Regulation 30 (LODR)-Scheme of Arrangement8 days ago
8 days agoClosure of Trading WindowSep 25, 2025
Sep 25, 2025Rumour verification - Regulation 30(11)Sep 20, 2025
Sep 20, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 19, 2025
Sep 19, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 06, 2025
Sep 06, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMSep 05, 2025
Sep 05, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 14, 2025
Aug 14, 2025Weblink Letter To Shareholders - As Per Regulation 36(1)(B) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Aug 13, 2025
Aug 13, 2025Weblink Letter To Shareholders - As Per Regulation 36(1)(B) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Aug 13, 2025
Aug 13, 2025Business Responsibility and Sustainability Reporting (BRSR)Aug 13, 2025
Aug 13, 2025Reg. 34 (1) Annual Report.Aug 13, 2025
Aug 13, 2025Notice Of The 23Rd Annual General Meeting (AGM) Of Vijaya Diagnostic Centre LimitedAug 13, 2025
Aug 13, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 12, 2025
Aug 12, 2025Corporate Action - Record Date Friday 29Th August 2025 Fixed For Dividend PaymentAug 12, 2025
Aug 12, 2025Information Relating To 23Rd Annual General Meeting (AGM) Record Date And Cut-Off Date For E-Voting & AGM.Aug 12, 2025
Aug 12, 2025Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSAug 04, 2025
Aug 04, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 02, 2025
Aug 02, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 30, 2025
Jul 30, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 29, 2025
Jul 29, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJul 28, 2025
Jul 28, 2025Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)Jul 28, 2025
Jul 28, 2025Announcement under Regulation 30 (LODR)-Investor PresentationJul 28, 2025
Jul 28, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 28, 2025
Jul 28, 2025Appointment Of Secretarial AuditorJul 28, 2025
Jul 28, 2025Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJul 28, 2025
Jul 28, 2025Board Meeting Outcome for Financial Results For The Quarter Ended June 30 2025Jul 28, 2025
Jul 28, 2025Financial Result For The Quarter Ended June 30 2025Jul 28, 2025
Jul 28, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 18, 2025
Jul 18, 2025Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended June 30 2025.Jul 18, 2025
Jul 18, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 17, 2025
Jul 17, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 02, 2025
Jul 02, 2025Closure of Trading WindowJun 26, 2025
Jun 26, 2025Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJun 07, 2025
Jun 07, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 29, 2025
May 29, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 20, 2025
May 20, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 15, 2025
May 15, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 13, 2025
May 13, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 12, 2025
May 12, 2025Announcement under Regulation 30 (LODR)-Investor PresentationMay 12, 2025
May 12, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 12, 2025
May 12, 2025Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSMay 12, 2025
May 12, 2025Announcement under Regulation 30 (LODR)-Change in ManagementMay 12, 2025
May 12, 2025Corporate Action-Board approves DividendMay 12, 2025
May 12, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On 12Th May 2025May 12, 2025
May 12, 2025Financial Results - For The 4Th Quarter And Financial Year Ended March 31 2025May 12, 2025
May 12, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 06, 2025
May 06, 2025Board Meeting Intimation for Approval Of Audited Financial Results For FY 2024-25 And Other Corporate MattersMay 06, 2025
May 06, 2025Unsecured Creditors Meeting - Scrutinizers Report And Voting ResultsApr 28, 2025
Apr 28, 2025Mutual Fund Holdings
Kotak Small Cap Fund Direct-Growth 
Nippon India Multi Cap Fund Direct-Growth 
Axis Small Cap Fund Direct-Growth 
HSBC Small Cap Fund Direct-Growth 
DSP Healthcare Fund Direct - Growth 
ICICI Prudential Innovation Fund Direct - Growth 
SBI Healthcare Opportunities Fund Direct Plan-Growth 
Edelweiss Small Cap Fund Direct - Growth 
Bank of India Small Cap Fund Direct-Growth 
Aditya Birla Sun Life Balanced Advantage Fund Direct-Growth 
WhiteOak Capital Flexi Cap Fund Direct - Growth 
Canara Robeco Value Fund Direct - Growth 
Motilal Oswal Small Cap Fund Direct - Growth Technical Indicators
RSI(14)
Neutral 37.36
ATR(14)
Volatile 27.78
STOCH(9,6)
Oversold 16.18
STOCH RSI(14)
Oversold 17.76
MACD(12,26)
Bearish -5.40
ADX(14)
Weak Trend 14.76
UO(9)
Bearish 32.98
ROC(12)
Downtrend And Accelerating -4.31
WillR(14)
Oversold -87.63
About Vijaya Diagnostic Centre
Vijaya Diagnostic Centre Limited is an Indian company founded in 1981 and incorporated in 2002. It is the largest integrated diagnostic chain in South India, providing a comprehensive range of diagnostic services including pathological investigations, radiology, nuclear medicine, and related healthcare services. The company operates over 121 diagnostic centers across 20 cities in India, offering laboratory services, radiology and imaging, cardiology, neurology, and gastroenterology services. In 2021, Vijaya Diagnostic Centre Limited went public with an IPO of Rs 1895.04 crore and its shares were listed on the BSE and NSE.
Listing Date
14 Sept, 2021(4 Years,
-6 days)
Chairperson NameSura Surendranath Reddy
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
